Navigation Links
IMRIS receives CE Mark approval for interventional imaging system
Date:4/30/2009

WINNIPEG, April 30 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced CE Mark approval for its integrated MR imaging and x-ray angiography suite that enables physicians to diagnose, intervene, resolve and confirm the effectiveness of treatment with one integrated system. With CE Mark approval, IMRIS will immediately commence marketing in Europe of two products: IMRISNV for stroke management and advanced neurovascular interventions and IMRIScardio for cardiovascular interventions.

IMRISNV features a 3T MRI scanner and a bi-plane angiography system specifically designed to co-exist in the same suite. Patients with acute ischemic stroke transition seamlessly from MR imaging to intervention without moving from the table. During and after the intervention, new MR images can be taken to assess the effectiveness of the treatment. IMRISNV is designed to shorten transition time between imaging modalities, decrease the overall time for treatment and improve patient outcomes.

IMRIScardio features a 1.5T MRI scanner that provides images that can improve the physician's ability to visualize the cardiovascular system before, during and after an intervention. With an integrated single-plane angiography system, IMRIScardio is designed to improve patient outcomes by decreasing the overall time for cardiovascular interventions and minimizing the patient's exposure to radiation and contrast media.

"CE Mark approval of our system represents our first step into the realm of neurovascular and cardiovascular interventional imaging", stated David Graves, CEO of IMRIS. "We are excited about launching our technology in Europe and we are confident that IMRISNV and IMRIScardio will help physicians and hospitals improve the outcomes of their patients suffering from a wide range of neurovascular and cardiovascular conditions."

About CE Mark

The CE Mark for medical devices is not a quality mark nor is it intended for consumers. It is a legally binding statement by the manufacturer that their product has met all of the requirements of the Medical Devices Directive (MDD 93/42/EEC), In Vitro Diagnostic Device Directive (IVD 98/79/EC) or the Active Implantable Medical Device Directive (AIMD 90/385/EEC), where applicable.

About IMRIS

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons for use in world-class neuroscience centers. For more information, visit www.imris.com.


'/>"/>
SOURCE IMRIS Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Huashan Hospital to install Asias first 3T IMRIS system for neurosurgery
2. IMRIS announces development program for MR guided radiation and interventional applications
3. IMRIS announces first IMRISneuro project in Australia
4. IMRISneuro: The iMRI technology of choice among the worlds top ranked hospitals
5. IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
6. Dell Childrens Medical Center to install IMRISneuro in expanded neurocenter
7. Senior GE Executive to lead IMRIS Sales team in the U.S.
8. University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
9. Providence St. Vincent bringing IMRISneuro, the worlds most advanced surgical MRI to Portland, Oregon
10. Insulet Receives CE Mark for the OmniPod(R) Insulin Management System
11. Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 09, 2016 , ... "I have gout, and I wanted to treat it ... is meant to relieve gout and pain caused by varicose veins. I drank it ... time. It relieved what VA doctors called the worst sinusitis case they'd seen and ...
(Date:12/9/2016)... ... December 09, 2016 , ... Sober ... anniversary with the grand opening of the Sober College Robert Pfeifer Memorial Learning ... days, December 2-3, and was attended by an overwhelming amount of alumni, family, ...
(Date:12/9/2016)... New York, NY (PRWEB) , ... December 09, 2016 , ... ... that raises awareness for organ transplantation while encouraging readers to sign up as an ... for a lifesaving organ transplant. , An organ donor can save up to ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... whiteboard display solutions, proudly announced today that a new solution for Emergency Departments ... fit in the tight space in Emergency Department examination rooms, and with a ...
(Date:12/9/2016)... ... 09, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... summer of 2016. The program was made possible by a Pennsylvania Department of ... Health and Human Services Administration. The broadcast, Use Your Head: Properly Managing ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... LONDON , Dec. 8, 2016 ... Summary GlobalData,s new report, "Australia Glaucoma ... market data on the Australia Glaucoma Surgery Devices ... US dollars, volume (in units) and average prices ... The report also provides company shares and ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... largest share of the market in 2016 and is ... can be attributed to a large number of surgical ... hold the largest share in the patient temperature management ... such as reducing loss of blood during surgeries, lowering ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
Breaking Medicine Technology: